OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group
Helena Linardou, Nikolaos Spanakis, Georgia-Angeliki Koliou, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4621-4621
Open Access | Times Cited: 37
Helena Linardou, Nikolaos Spanakis, Georgia-Angeliki Koliou, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4621-4621
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 390
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 390
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 178
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 178
The Effect of Smoking on Humoral Response to COVID-19 Vaccines: A Systematic Review of Epidemiological Studies
Pietro Ferrara, Vincenza Gianfredi, Venera Tomaselli, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 303-303
Open Access | Times Cited: 73
Pietro Ferrara, Vincenza Gianfredi, Venera Tomaselli, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 303-303
Open Access | Times Cited: 73
Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection
John Charles Rotondo, Fernanda Martini, Martina Maritati, et al.
Microorganisms (2022) Vol. 10, Iss. 6, pp. 1193-1193
Open Access | Times Cited: 52
John Charles Rotondo, Fernanda Martini, Martina Maritati, et al.
Microorganisms (2022) Vol. 10, Iss. 6, pp. 1193-1193
Open Access | Times Cited: 52
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses
Jeffrey Tomalka, Mehul S. Suthar, Steven G. Deeks, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 360-370
Open Access | Times Cited: 38
Jeffrey Tomalka, Mehul S. Suthar, Steven G. Deeks, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 360-370
Open Access | Times Cited: 38
Immunogenicity and Safety of COVID-19 Vaccines in Patients with Pancreatic Cancer
Leonoor V. Wismans, Rory D. de Vries, Casper W.F. van Eijck, et al.
HPB (2025)
Open Access
Leonoor V. Wismans, Rory D. de Vries, Casper W.F. van Eijck, et al.
HPB (2025)
Open Access
Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis
Durgesh Wankhede, Sandeep Grover, Paul Hofman
Vaccine (2023) Vol. 41, Iss. 11, pp. 1791-1798
Open Access | Times Cited: 12
Durgesh Wankhede, Sandeep Grover, Paul Hofman
Vaccine (2023) Vol. 41, Iss. 11, pp. 1791-1798
Open Access | Times Cited: 12
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis
Εfstathia Liatsou, Ioannis Ntanasis‐Stathopoulos, Stavros Lykos, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2266-2266
Open Access | Times Cited: 10
Εfstathia Liatsou, Ioannis Ntanasis‐Stathopoulos, Stavros Lykos, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2266-2266
Open Access | Times Cited: 10
Cohort profile:Stop the Spread Ottawa (SSO)—a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination
Erin Collins, Yannick Galipeau, Corey Arnold, et al.
BMJ Open (2022) Vol. 12, Iss. 9, pp. e062187-e062187
Open Access | Times Cited: 15
Erin Collins, Yannick Galipeau, Corey Arnold, et al.
BMJ Open (2022) Vol. 12, Iss. 9, pp. e062187-e062187
Open Access | Times Cited: 15
Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis
Tiantian Hua, Rui Fan, Fan Yang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Tiantian Hua, Rui Fan, Fan Yang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery
Maristella Bungaro, Francesco Passiglia, Giorgio V. Scagliotti
Biomedicines (2022) Vol. 10, Iss. 4, pp. 776-776
Open Access | Times Cited: 11
Maristella Bungaro, Francesco Passiglia, Giorgio V. Scagliotti
Biomedicines (2022) Vol. 10, Iss. 4, pp. 776-776
Open Access | Times Cited: 11
COVID-19 and Cancer: Special Considerations for Patients Receiving Immunotherapy and Immunosuppressive Cancer Therapies
Jason D. Goldman, Michael A. Gonzalez, Maria Madeleine Rüthrich, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 176-188
Open Access | Times Cited: 10
Jason D. Goldman, Michael A. Gonzalez, Maria Madeleine Rüthrich, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 176-188
Open Access | Times Cited: 10
Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine
Sutima Luangdilok, Passakorn Wanchaijiraboon, Nussara Pakvisal, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1613-1613
Open Access | Times Cited: 10
Sutima Luangdilok, Passakorn Wanchaijiraboon, Nussara Pakvisal, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1613-1613
Open Access | Times Cited: 10
SARS-CoV-2 vaccination willingness and humoral vaccination response in radiation oncology patients
Hans Geinitz, Elisabeth Silberberger, Kurt Spiegl, et al.
Vaccine (2024) Vol. 42, Iss. 4, pp. 945-959
Open Access | Times Cited: 1
Hans Geinitz, Elisabeth Silberberger, Kurt Spiegl, et al.
Vaccine (2024) Vol. 42, Iss. 4, pp. 945-959
Open Access | Times Cited: 1
Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature
Panagiota Tsagkli, Maria Geropeppa, Ioanna Papadatou, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 1
Panagiota Tsagkli, Maria Geropeppa, Ioanna Papadatou, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 1
mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients
Maria Teresa Lupo Stanghellini, Serena Di Cosimo, Massimo Costantini, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Maria Teresa Lupo Stanghellini, Serena Di Cosimo, Massimo Costantini, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis
Juntao Yin, Yangyang Chen, Yang Li, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 7
Juntao Yin, Yangyang Chen, Yang Li, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 7
Vaccine third dose and cancer patients: necessity or luxury?
Γεώργιος Παππάς, Emmanouil Saloustros, Anastasios Boutis, et al.
ESMO Open (2021) Vol. 6, Iss. 6, pp. 100306-100306
Open Access | Times Cited: 9
Γεώργιος Παππάς, Emmanouil Saloustros, Anastasios Boutis, et al.
ESMO Open (2021) Vol. 6, Iss. 6, pp. 100306-100306
Open Access | Times Cited: 9
The Interplay of Lung Cancer, COVID-19, and Vaccines
Dragan Trivanović, Željka Peršurić, Andrea Agaj, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15067-15067
Open Access | Times Cited: 6
Dragan Trivanović, Željka Peršurić, Andrea Agaj, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15067-15067
Open Access | Times Cited: 6
COVID-19 Vaccination Safety Profiles in Patients With Solid Tumour Cancers: A Systematic Review
S.L. Shear, K. Shams, Jake Weisberg, et al.
Clinical Oncology (2023) Vol. 35, Iss. 7, pp. e421-e433
Open Access | Times Cited: 2
S.L. Shear, K. Shams, Jake Weisberg, et al.
Clinical Oncology (2023) Vol. 35, Iss. 7, pp. e421-e433
Open Access | Times Cited: 2
COVID-19 vaccination status, side effects, and perceptions among breast cancer survivors: a cross-sectional study in China
Yali Xu, Linrong Li, Xiaomeng Li, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 2
Yali Xu, Linrong Li, Xiaomeng Li, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 2
SARS-CoV-2 Vaccination in Patients with Cancer and COVID-19 in Mexico
Corazón Barrientos-Flores, Diana Vilar‐Compte, Nancy Martínez-Rivera, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1163-1163
Open Access
Corazón Barrientos-Flores, Diana Vilar‐Compte, Nancy Martínez-Rivera, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1163-1163
Open Access
Does Tobacco Smoking Affect Vaccine-Induced Immune Response? A Systematic Review and Meta-Analysis
Federica Valeriani, Carmela Protano, Angela Pozzoli, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1260-1260
Open Access
Federica Valeriani, Carmela Protano, Angela Pozzoli, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1260-1260
Open Access
COVID-19 Vaccine Safety Studies among Vulnerable Populations: A Systematic Review and Meta-analysis of 120 Observational Studies and Randomized Clinical Trials
Sima Mohammadi, Malede Mequanent Sisay, Putri Widi Saraswati, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Sima Mohammadi, Malede Mequanent Sisay, Putri Widi Saraswati, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Immune Response to SARS-CoV-2 Vaccination in Cancer Patients: A Prospective Study
Cecília Caramujo, Inês Gomes, Teresa Fraga, et al.
Cureus (2023)
Open Access | Times Cited: 1
Cecília Caramujo, Inês Gomes, Teresa Fraga, et al.
Cureus (2023)
Open Access | Times Cited: 1
